FindTrial
Sign In

FoundationOne liquid CDx

DIAGNOSTIC_TEST2 trials

Sponsors

British Columbia Cancer Agency, Dana-Farber Cancer Institute

Conditions

CancerEwing SarcomaEwing Sarcoma of BoneEwing Sarcoma of Soft TissueHigh-grade OsteosarcomaPeripheral Primitive Neuroectodermal TumorPeripheral Primitive Neuroectodermal Tumor of BonePeripheral Primitive Neuroectodermal Tumor of Soft Tissue

Unknown Phase

PRecision Oncology Evidence Development in Cancer Treatment - Liquid
Active, not recruitingNCT05057234
British Columbia Cancer AgencyCancer
Start: 2021-06-18End: 2027-06-01Target: 1500Updated: 2025-09-25
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
Active, not recruitingNCT06068075
Dana-Farber Cancer InstituteEwing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue +4
Start: 2018-05-08End: 2027-01-01Target: 340Updated: 2026-05-05

Related Papers

Association between genetic information provision and decisional conflict in patients with cancer.
JCO Oncology Practice2024-09-30
Patient-reported outcomes in a linguistically diverse cancer population: Addressing barriers to access.
Journal of Clinical Oncology2022-09-30